Sharecast
United Kingdom
Italian
Spanish
Portuguese
French
German
Chinese (Sim.)
Chinese (Tra.)
Russian
Danish
Croatian
Dutch
Finnish
Japanese
Swedish
Norwegian
Polish
Romanian
Serbian
Turkish
Indonesian
Bosnian
Bulgarian
Catalan
Czech
Greek
Afrikaans
Albanian
Amharic
Arabic
Armenian
Azerbaijani
Basque
Belarusian
Bengali
Cebuano
Chichewa
Corsican
sharecast
Summary
Home
UK Shares
UK SHARES
Home
Results
Broker Views
Director Dealings
IPO Centre
Company Diary
Regulatory News
Company A-Z
Market Data
MARKET DATA
Overview
Indices
Currencies
Commodities
Gilts
ETFS
Bonds
Sharecast News
Cryptocurrencies
Technical Analysis
Active Trader
Funds
FUNDS
Funds Centre
Managers
News
Brokers
BROKERS
Home
Forex
Shares
Binary Options
CFDs
Futures
Options
Spread Betting
Learn on finance
Spread Bet
SPREAD BET
Learn
Strategies
Economic calendar
Portfolio
Watchlist
More
Home
UK Shares
Home
Results
Broker Views
Director Dealings
IPO Centre
Company Diary
Regulatory News
Company A-Z
Market Data
Overview
Indices
Currencies
Commodities
Gilts
ETFS
Bonds
Sharecast News
Cryptocurrencies
Technical Analysis
Active Trader
Funds
Funds Centre
Managers
News
Brokers
Home
Forex
Shares
Binary Options
CFDs
Futures
Options
Spread Betting
Learn on finance
Spread Bet
Learn
Strategies
Economic calendar
Portfolio
Watchlist
Sector
Pharma and Biotech
Indices
FTSE AIM
Faron Pharmaceuticals Oy (DI) (FARN)
151.96p
13:50 04/02/25
-6.49%
-10.54p
Today's Low & High
150.00 / 165.00
Open / Previous Close
165.00 / 162.50
52-week range
-47.05%
-135.04p
Volume
29,410
Market Cap(million)
£158.98m
Advertising
Summary
KEY FINANCIALS
Income & Efficiency
Valuation
Growth
Latest
Forecast
Div Yield
0.0%
0.0%
Div Cover
n/a
n/a
Op Mrgn
0.0%
-101.4%
ROCE
910.4%
Latest
Forecast
P/E
-4.1
0.0
PEG
0.0
-999,999.0
Price / Revenue
0.0
7.1
Price / Book value
-13.5
Latest
Forecast
Revenue
0.0%
1.1%
PBT
0.0%
n/a
EPS
0.0%
-8.1%
DPS
n/a
0.0%
KEY FUNDAMENTALS
Year Ending
Revenue
(€m)
Pre-tax
(€m)
EPS
P/E
PEG
EPS Growth
Div
Yield
2020-12-31
n/a
-16.93
€-0.37
-7.9
0.0
n/a
n/a
0.0%
2021-12-31
n/a
-21.18
€-0.42
-7.6
0.0
n/a
n/a
0.0%
2022-12-31
0.00
-28.73
€-0.52
-6.5
0.0
n/a
n/a
0.0%
2023-12-31
0.00
-30.94
€-0.48
-7.3
0.0
n/a
n/a
0.0%
Latest Webfg News
Faron identifies final patient in BEXMAB phase two study
Sharecast News
31 Jan
Faron Pharmaceuticals reports regulatory progress in the UK
Sharecast News
02 Dec
Faron announces promising MDS trial results
Sharecast News
27 Nov
More Webfg News
Regulatory News
Faron’s Financial Calendar for 2025
13-Dec-24 07:01
Positive Phase 2 Interim Results from BEXMAB Trial
27-Nov-24 07:01
Shareholders’ Nomination Board
05-Nov-24 07:01
read more news
Loading:
Login with Google
o
Log in
Remember me
Forgot password?
Don’t have an account?
Sign In